Developments in Leishmaniasis diagnosis: A patent landscape from 2010 to 2022.

ABSTRACT: The current study aims to contribute to the understanding of leishmaniasis diagnosis by providing an overview of patent filings in this field and analyzing whether the methods revealed are consistent with the needs described by the scientific community, in special the main gaps detected by the World Health Organization's 2021-2030 Roadmap for Neglected Tropical Diseases. To this aim, a patent search was carried out focusing on documents disclosing leishmaniasis diagnostic methods supported by experimental evidence and with earliest priority date from 2010 onwards. Our results show that patenting activity is low and patent families are often formed by individual filings. Most R&D activity occurs in Brazil, which is also the main market of protection. Brazilian academic institutions are the

SUBMITTER: de Avelar DM 

PROVIDER: S-EPMC10619796 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature